Comparison of colistin monotherapy and non-colistin combinations in the treatment of multi-drug resistant Acinetobacter spp. bloodstream infections: A Multicenter retrospective analysis
dc.authorid | Ozturk-Engin, Derya/0000-0002-2566-7317 | |
dc.authorid | Karabay, Oguz/0000-0003-1514-1685 | |
dc.authorid | Sezak, Nurbanu/0000-0001-9472-1340 | |
dc.authorid | Durdu, Bulent/0000-0002-0244-4006 | |
dc.authorid | Karahocagil, Mustafa Kasım/0000-0002-5171-7306 | |
dc.authorid | balkan, ilker inanc/0000-0002-8977-5931 | |
dc.authorid | altay, fatma aybala/0000-0002-7149-2968 | |
dc.authorwosid | Ozturk-Engin, Derya/AFG-5927-2022 | |
dc.authorwosid | Karabay, Oguz/HHN-5893-2022 | |
dc.authorwosid | Örmen, Bahar/ABA-1027-2021 | |
dc.authorwosid | Sezak, Nurbanu/JWA-2218-2024 | |
dc.authorwosid | sezak, nurbanu/HGT-9467-2022 | |
dc.authorwosid | Hosoglu, Salih/AGH-2653-2022 | |
dc.authorwosid | Durdu, Bulent/I-7851-2016 | |
dc.contributor.author | Balkan, Ilker Inanc | |
dc.contributor.author | Batirel, Ayse | |
dc.contributor.author | Karabay, Oguz | |
dc.contributor.author | Agalar, Canan | |
dc.contributor.author | Akalin, Serife | |
dc.contributor.author | Alici, Ozlem | |
dc.contributor.author | Alp, Emine | |
dc.date.accessioned | 2024-06-12T10:54:53Z | |
dc.date.available | 2024-06-12T10:54:53Z | |
dc.date.issued | 2015 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Objectives: To compare the efficacy of colistin (COL) monotherapy versus non-COL based combinations in the treatment of bloodstream infections (BSIs) due to multidrug resistant Acinetobacter spp.(MDR-A) . Materials and Methods: Retrospective data of 107 MDR-A BSI cases from 27 tertiary centers in Turkey were included. Primary End-Point: 14-day mortality. Secondary End-Points: Microbial eradication and clinical improvement. Results: Thirty-six patients in the COL monotherapy (CM) group and 71 in the non-COL based combinations (NCC) group were included in the study. Mean age was 59.98 20 years (range: 18-89) and 50.5% were male. Median duration of follow-up was 40 days (range: 9-297). The 14-day survival rates were 52.8% in CM and 47.23% in NCC group (P = 0.36). Microbiological eradication was achieved in 69% of CM and 83% of NCC group (P = 0.13). Treatment failure was detected in 22.9% of cases in both CM and NCC groups. Univariate analysis revealed that mean age (P = 0.001), Charlson comorbidity index (P = 0.03), duration of hospital stay before MDR-A BSI (P = 0.04), Pitt bacteremia score (P = 0.043) and Acute Physiology and Chronic Health Evaluation II score (P = 0.05) were significant in terms of 14-day mortality. Advanced age (P = 0.01) and duration of hospital stay before MDR-A BSI (P = 0.04) were independently associated with 14-day mortality in multivariate analysis. Conclusion: No significant difference was detected between CM and non-COL based combinations in the treatment of MDR-A BSIs in terms of efficacy and 14-day mortality. | en_US |
dc.identifier.doi | 10.4103/0253-7613.150383 | |
dc.identifier.endpage | 100 | en_US |
dc.identifier.issn | 0253-7613 | |
dc.identifier.issn | 1998-3751 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 25821319 | en_US |
dc.identifier.scopus | 2-s2.0-84923055629 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 95 | en_US |
dc.identifier.uri | https://doi.org/10.4103/0253-7613.150383 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/19202 | |
dc.identifier.volume | 47 | en_US |
dc.identifier.wos | WOS:000349144300018 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wolters Kluwer Medknow Publications | en_US |
dc.relation.ispartof | Indian Journal Of Pharmacology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Blood Stream Infection | en_US |
dc.subject | Colistin | en_US |
dc.subject | Monotherapy | en_US |
dc.subject | Multi Drug Resistant Acinetobacter Spp | en_US |
dc.subject | Gram-Negative Bacteria | en_US |
dc.subject | Critically-Ill Patients | en_US |
dc.subject | Baumannii Bacteremia | en_US |
dc.subject | Risk-Factors | en_US |
dc.subject | Antimicrobial Therapy | en_US |
dc.subject | Mortality | en_US |
dc.subject | Outcomes | en_US |
dc.subject | Impact | en_US |
dc.subject | Appropriate | en_US |
dc.subject | Sulbactam | en_US |
dc.title | Comparison of colistin monotherapy and non-colistin combinations in the treatment of multi-drug resistant Acinetobacter spp. bloodstream infections: A Multicenter retrospective analysis | en_US |
dc.type | Article | en_US |